Cargando…
Altered microRNA expression in animal models of Huntington’s disease and potential therapeutic strategies
A review of recent animal models of Huntington’s disease showed many microRNAs had altered expression levels in the striatum and cerebral cortex, and which were mostly downregulated. Among the altered microRNAs were miR-9/9*, miR-29b, miR-124a, miR-132, miR-128, miR-139, miR-122, miR-138, miR-23b, m...
Autores principales: | Martinez, Bridget, Peplow, Philip V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354140/ https://www.ncbi.nlm.nih.gov/pubmed/33818488 http://dx.doi.org/10.4103/1673-5374.310673 |
Ejemplares similares
-
MicroRNA expression in animal models of amyotrophic lateral sclerosis and potential therapeutic approaches
por: Martinez, Bridget, et al.
Publicado: (2021) -
MicroRNAs as biomarkers in glaucoma and potential therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2022) -
MicroRNAs in laser-induced choroidal neovascularization in mice and rats: their expression and potential therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2020) -
MicroRNAs in mouse and rat models of experimental epilepsy and potential therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2023) -
MicroRNAs in Parkinson's disease and emerging therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2017)